PHAX Antibody

Basic Research Questions

• What is the function of PHAX protein in cellular processes?

PHAX serves as a critical adapter protein involved in RNA transport and processing mechanisms. Specifically, PHAX is a key player in the nucleocytoplasmic transport of small RNAs, such as U snRNAs and small nucleolar RNAs (snoRNAs), which are essential for proper gene expression regulation . Recent research has revealed PHAX's unexpected role in DNA damage response (DDR) through the regulation of histone H2AX expression . PHAX knockdown leads to significant reduction in H2AX expression levels by inhibiting both H2AX mRNA export and H2AX promoter activity, resulting in impaired DNA repair capability . This dual functionality in both RNA transport and genome stability maintenance makes PHAX an important target for studies in molecular and cellular biology.

• What experimental applications are PHAX antibodies validated for?

PHAX antibodies have been validated for multiple experimental applications, with specific recommendations for each technique:

Researchers should always perform antibody validation in their specific experimental system. Successful detection has been reported in various cell lines including A549 and HeLa cells . When selecting a PHAX antibody, consider the specific epitope it targets, as different antibodies recognize different regions of the protein, which may affect detection depending on protein conformation or post-translational modifications .

• How should PHAX antibodies be stored and handled for optimal performance?

For maximum stability and activity, PHAX antibodies should be stored at -20°C . Most commercial PHAX antibodies are provided in a buffered aqueous glycerol solution (typically 50% glycerol with 0.01M PBS, pH 7.4), which helps maintain antibody stability . Some preparations may contain preservatives such as 0.03% Proclin 300 .

When working with the antibody:

• Avoid repeated freeze-thaw cycles, which can cause protein denaturation and loss of activity

• Aliquot upon initial thawing if multiple experiments are planned

• Allow antibody to reach room temperature before opening the vial to prevent condensation

• Always centrifuge briefly before use to collect all liquid at the bottom of the tube

• Use RNase-free conditions when working with PHAX antibodies for RNA-related experiments, as PHAX's function in RNA transport may be relevant to your research

Advanced Research Considerations

• How can I validate PHAX antibody specificity for my experimental system?

Following the "five pillars" of antibody characterization is crucial for PHAX antibody validation :

• Genetic strategies: Use PHAX knockdown or knockout cells as negative controls. Studies have shown that PHAX knockdown by siRNA provides an excellent specificity control .

• Orthogonal strategies: Compare results from antibody-dependent methods (e.g., Western blot) with antibody-independent techniques (e.g., mass spectrometry or RT-PCR for PHAX mRNA expression).

• Multiple antibody strategy: Use different antibodies targeting distinct PHAX epitopes. Commercial options include antibodies targeting the C-terminal region (amino acids 304-334) , internal regions , and N-terminal portions (amino acids 6-243) .

• Recombinant expression strategy: Overexpress PHAX in your system as a positive control. Research shows that transfecting cells with a PHAX-expressing plasmid can restore PHAX-dependent functions and serve as a positive control .

• Immunocapture MS strategy: Use mass spectrometry to identify proteins captured by your PHAX antibody, confirming you're pulling down actual PHAX protein rather than cross-reactive targets.

When publishing results using PHAX antibodies, researchers should clearly document which validation methods were used, as poor antibody characterization contributes to the reproducibility crisis in biomedical research .

• What are the critical considerations when designing experiments to study PHAX's role in RNA transport versus DNA damage response?

When designing experiments to distinguish between PHAX's dual roles, consider:

For RNA transport studies:

• Use cellular fractionation to separate nuclear and cytoplasmic components to track RNA movement

• Employ microinjection experiments with labeled RNA substrates and anti-PHAX antibodies to visualize transport inhibition

• Analyze both nascent and processed RNAs through pulse-labeling with 5-ethynyl uridine (5EU)

• Focus on U snRNAs and snoRNAs, which are the primary substrates for PHAX-mediated transport

For DNA damage response studies:

• Use DNA damaging agents like UV irradiation, adriamycin (ADR), or camptothecin (CPT) to trigger the response

• Monitor both total H2AX and phosphorylated H2AX (γH2AX) levels

• Assess cell viability and DNA repair capacity after PHAX knockdown

• Analyze PHAX-dependent changes in chromatin immunoprecipitation (ChIP) of RNA polymerase II at histone gene loci

Cross-validate findings by rescue experiments: "When the PHAX-KD cells were transfected with a PHAX-expressing plasmid, the γH2AX expression level was largely restored," indicating the specificity of the observed effects .

• How can I distinguish between direct and indirect effects of PHAX in my experimental results?

Distinguishing direct from indirect effects of PHAX requires sophisticated experimental design:

• Temporal analysis: Study immediate versus delayed effects following PHAX manipulation. Direct effects typically manifest rapidly after PHAX perturbation.

• Domain-specific mutants: Generate PHAX constructs with mutations in specific functional domains to dissect which activities are responsible for observed phenotypes:

  • RNA-binding domain mutations

  • Phosphorylation site mutations

  • Nuclear localization signal mutations

• Interactome analysis: Use co-immunoprecipitation with PHAX antibodies followed by mass spectrometry to identify direct binding partners versus proteins affected downstream .

• Proximity labeling: Employ BioID or APEX2 fused to PHAX to identify proteins in close proximity in living cells.

• Conditional systems: Use inducible PHAX knockdown or expression systems to control the timing of PHAX manipulation, allowing better dissection of primary versus secondary effects.

Research has shown that PHAX affects both H2AX mRNA export and transcription , representing both direct (transport) and potentially indirect (transcriptional) effects. Control experiments should include measuring the effects on other genes to determine specificity.

• How do different PHAX antibodies perform in detecting post-translational modifications of PHAX?

PHAX function is regulated through phosphorylation, which affects its activity in RNA transport. When selecting antibodies for studying PHAX post-translational modifications:

Research indicates that PHAX phosphorylation status affects its interactions with other proteins in RNA export complexes . When studying these interactions, careful selection of antibodies that don't disrupt or artificially enhance these interactions is critical.

Experimental Methodology

• What are optimal protocols for immunoprecipitation of PHAX and its associated complexes?

For successful immunoprecipitation of PHAX and its protein complexes:

Buffer composition is critical:

• Use HNTG buffer (20 mM HEPES pH 7.9, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM MgCl2, 1 mM EGTA with complete anti-protease cocktail)

• Include phosphatase inhibitors (e.g., 1 mM NaF, 1 mM Na3VO4) to preserve phosphorylation states

• For RNA-associated complexes, add RNase inhibitors

Immunoprecipitation protocol:

• Start with nuclear fractionation for enrichment of PHAX-containing complexes

• Use protein G-sepharose beads coupled to PHAX antibodies or GFP-Trap beads for tagged PHAX variants

• Include appropriate controls (e.g., IgG, pre-immune serum)

• Wash with HNTG buffer at least 4 times

• Elute with Laemmli buffer for standard analysis or use more gentle elution (e.g., peptide competition) to preserve complex integrity

Analysis of PHAX complexes:

• Western blotting to detect known partners such as CBC, CRM1, and snoRNP proteins

• Mass spectrometry for unbiased identification of interactors

• RT-PCR or RNA-seq of co-immunoprecipitated RNAs to identify bound transcripts

For studying RNA-protein interactions, consider cross-linking prior to immunoprecipitation (CLIP approaches) to stabilize transient interactions.

• How can I use PHAX antibodies to investigate the relationship between PHAX and DNA damage response pathways?

To investigate PHAX's role in DNA damage response using PHAX antibodies:

• Induction of DNA damage:

  • Use UV irradiation (documented effective dose: standard cell culture UV dose)

  • Alternative agents: adriamycin (ADR) or camptothecin (CPT)

  • Include time course (0-24h) to capture dynamic responses

• PHAX-γH2AX relationship analysis:

  • Perform co-immunofluorescence with anti-PHAX and anti-γH2AX antibodies

  • Quantify γH2AX foci formation in PHAX-positive versus PHAX-depleted cells

  • Use ChIP with PHAX antibodies to assess PHAX recruitment to damage sites

• Functional studies:

  • Establish PHAX knockdown cell lines using siRNA

  • Measure cell viability after DNA damage (research shows significantly reduced viability in PHAX-KD cells)

  • Monitor phosphorylation of key DDR factors (ATM, DNA-PKcs, p53)

  • Assess DNA repair capacity through comet assay or other repair assays

• Mechanistic investigation:

  • Perform rescue experiments with wild-type versus mutant PHAX constructs

  • Use RNA immunoprecipitation to capture PHAX-bound transcripts during DDR

  • Analyze H2AX mRNA export using cellular fractionation followed by qRT-PCR

Research has shown that "PHAX-KD cells were not able to induce efficient H2AX protein expression and hence efficient DNA damage repair," making this a critical area for investigation .

• What approaches can be used to apply PhIP-Seq technology with PHAX antibodies for autoantibody and epitope discovery?

PhIP-Seq (Phage Immunoprecipitation Sequencing) represents an advanced application for PHAX antibodies in epitope mapping and autoantibody discovery:

• Library design for PHAX epitope mapping:

  • Create overlapping peptide libraries covering the entire PHAX protein sequence

  • Typical design uses 36-50 amino acid peptides with 25 amino acid overlaps

  • Express peptides as fusions to T7 phage coat proteins

• Immunoprecipitation protocol:

  • Immobilize PHAX antibodies on protein A/G beads

  • Incubate with phage library displaying PHAX peptides

  • Perform stringent washing to remove non-specific binding

  • Elute bound phages and extract phage DNA

• Next-generation sequencing analysis:

  • Barcode samples for multiplexing

  • Use next-generation sequencing to identify enriched peptides

  • Apply statistical analysis to identify significantly enriched epitopes

• Applications for PHAX research:

  • Precise epitope mapping of existing PHAX antibodies

  • Discovery of autoantibodies against PHAX in disease contexts

  • Investigation of conformational epitopes using longer overlapping peptides

For autoantibody discovery, patient serum can be screened against PHAX peptide libraries to identify potential disease-specific epitopes. The PhIP-Seq approach provides "a high-throughput method for identifying antigens/epitopes of the antibody reactome" , making it valuable for comprehensive characterization of antibody responses to PHAX.

• How do different fixation and permeabilization methods affect PHAX antibody performance in immunofluorescence studies?

The choice of fixation and permeabilization methods significantly impacts PHAX detection by immunofluorescence:

• Comparison of fixation methods:

  • Paraformaldehyde (4%): Recommended standard approach; preserves morphology while allowing antibody accessibility

  • Methanol fixation: May expose different epitopes but can destroy some antigenic sites

  • Methanol-acetone: Alternative for certain antibodies with poor performance in PFA

  • Glyoxal-based fixatives: Consider for improved ultrastructural preservation

• Permeabilization optimization:

  • Triton X-100 (0.1%): Standard approach for nuclear protein detection

  • Saponin (0.1%): Gentler alternative that may preserve delicate structures

  • Digitonin (10-50 μg/ml): Selective permeabilization of plasma membrane only; useful for distinguishing cytoplasmic versus nuclear PHAX

• Protocol recommendations:

  • For standard PHAX detection: 4% PFA for 10-15 minutes followed by 0.1% Triton X-100

  • For co-localization with RNA: Consider shorter fixation times to preserve RNA

  • For PHAX phosphorylation studies: Include phosphatase inhibitors in all buffers

• Technical considerations:

  • Perform parallel fixation methods when first optimizing a new PHAX antibody

  • Include appropriate controls (PHAX-depleted cells)

  • For quantitative analysis, ensure consistent fixation time and temperature

Research using PHAX antibodies for immunofluorescence has shown successful detection in HeLa cells fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 . This approach allows visualization of PHAX's predominantly nuclear localization.

Research Applications and Data Interpretation

• How can I use PHAX antibodies to investigate RNA export mechanisms in different cell types or disease models?

To investigate RNA export using PHAX antibodies across different experimental systems:

• Cell type-specific analysis:

  • Compare PHAX expression levels and localization across cell types using immunoblotting and immunofluorescence

  • Correlate with snRNA/snoRNA export efficiency measured by cellular fractionation and RT-qPCR

  • Consider PHAX phosphorylation status, which regulates its activity in export complexes

• Disease model applications:

  • Cancer models: Examine altered PHAX expression/localization in cancer cells, which may relate to dysregulated RNA metabolism

  • Neurological disorders: Investigate PHAX in models with RNA processing defects

  • Viral infections: Study how viruses impact PHAX-mediated RNA export pathways

• Experimental approaches:

  • Microinjection assays: Microinject labeled RNA substrates along with PHAX antibodies to visualize transport inhibition in living cells

  • RNA immunoprecipitation: Use PHAX antibodies to capture bound RNAs, followed by sequencing to identify cargo

  • Live cell imaging: Combine with GFP-tagged RNA binding proteins to track export dynamics

• Advanced technical considerations:

  • Use leptomycin B (7nM) treatment to inhibit CRM1-dependent export as a control

  • Consider wheat germ agglutinin (WGA) at 2.5 mg/ml to block nuclear pores

  • For heterokaryon assays, anti-PHAX antibodies can help monitor shuttling properties

Research has demonstrated that "microinjection of the antibody against PHAX inhibited the export of processed H2A mRNA but not the control mRNA," providing a powerful tool for mechanistic studies .

• What are the main challenges in interpreting PHAX antibody data from different experimental systems?

Researchers face several challenges when interpreting PHAX antibody data across experimental systems:

• Epitope accessibility variations:

  • PHAX conformation may differ based on phosphorylation status

  • Protein-protein interactions may mask antibody epitopes

  • Nuclear localization may affect antibody penetration efficiency

• Specificity considerations:

  • Cross-reactivity profiles may vary between applications (WB vs. IF)

  • Background signals differ between cell types due to varying expression of related proteins

  • Post-translational modifications may affect antibody recognition

• Quantitative interpretation challenges:

  • Establishing appropriate normalization controls (housekeeping proteins vary between cell types)

  • Accounting for extraction efficiency differences when comparing nuclear proteins

  • Linear range determination for quantitative western blotting of PHAX

• Solution strategies:

  • Multiple antibody approach: Use antibodies targeting different PHAX epitopes to validate findings

  • Genetic controls: Include PHAX knockdown/knockout samples as negative controls

  • Recombinant standards: Use purified PHAX protein as quantification standards

  • Careful documentation: Record exact fixation times, antibody lots, and image acquisition settings

• Data integration perspective:

  • Integrate findings from orthogonal methods (e.g., MS, functional assays)

  • Consider cellular context (e.g., cell cycle stage, stress conditions)

  • Account for potential differences in PHAX isoform expression

The antibody characterization crisis highlighted in research literature emphasizes that "~50% of commercial antibodies fail to meet even basic standards for characterization," underscoring the importance of rigorous validation in each experimental system .

• How can I design multiplexed immunofluorescence experiments to study PHAX interactions with other RNA export factors?

Designing effective multiplexed immunofluorescence experiments for PHAX and its partners:

• Antibody selection strategy:

  • Choose primary antibodies raised in different host species (e.g., rabbit anti-PHAX with mouse anti-CRM1)

  • Verify that selected antibodies detect native proteins at endogenous levels

  • Test each antibody individually before multiplexing to establish baseline signals

• Experimental design for RNA export pathway:

  • Key interaction partners to include: CBC (Cap Binding Complex), CRM1, and snoRNP proteins

  • Sequential staining approach: For antibodies from the same species, use sequential labeling with intermediate blocking steps

  • Controls: Include single-stained samples for spectral unmixing and compensation

• Advanced multiplexing methods:

  • Tyramide signal amplification: Allows use of multiple antibodies from same species

  • Spectral imaging: Resolves overlapping fluorophores through spectral unmixing

  • Cyclic immunofluorescence: Sequential staining/stripping for >10 targets on same sample

• Analysis approaches:

  • Colocalization analysis: Measure Pearson's or Mander's coefficients between PHAX and partners

  • Proximity analysis: Use techniques like Proximity Ligation Assay (PLA) to detect PHAX-partner interactions within 40nm

  • FRET/FLIM: For studying direct protein-protein interactions between fluorescently tagged proteins

• Biological perturbations to include:

  • RNA synthesis inhibition (actinomycin D)

  • Nuclear export inhibition (leptomycin B at 7nM)

  • DNA damage induction (to study PHAX redistribution)

Research has shown that PHAX participates in "pre-snoRNA complexes" that contain "factors involved in transport (CBC, PHAX and CRM1)" , making these ideal targets for multiplexed imaging studies.

• What are the key considerations when using PHAX antibodies for chromatin immunoprecipitation (ChIP) studies?

For successful PHAX ChIP experiments, consider these critical factors:

• Cross-linking optimization:

  • Standard formaldehyde (1%) for 10 minutes works for many nuclear factors

  • Consider dual cross-linking with formaldehyde plus disuccinimidyl glutarate (DSG) for improved capture of protein-protein interactions

  • Test cross-linking time series (5-15 min) to optimize for PHAX

• Chromatin preparation considerations:

  • Sonication conditions must be optimized for each cell type (aim for 200-500bp fragments)

  • Verify sonication efficiency by agarose gel electrophoresis before proceeding

  • Include chromatin pre-clearing step to reduce background

• Antibody selection and validation:

  • Select antibodies specifically validated for ChIP applications

  • Verify antibody specificity via IP-Western before ChIP

  • Include IgG control and input samples for normalization

• Data analysis and interpretation:

  • For PHAX ChIP-qPCR, focus on histone gene loci, particularly H2AX, where research shows PHAX involvement

  • Research indicates "RNAPII recruitments to H2AA and H2AX gene loci were reduced in PHAX-KD cells"

  • Compare PHAX binding with RNA polymerase II occupancy to establish functional relationships

• Advanced considerations:

  • For genome-wide analysis, consider ChIP-seq to identify all PHAX binding sites

  • For simultaneous study of PHAX and other factors, use sequential ChIP (Re-ChIP)

  • To study PHAX-RNA interactions at chromatin, combine with CLIP techniques

Research has demonstrated that PHAX affects "histone mRNA transcription," suggesting chromatin association . When designing primers for ChIP-qPCR, include regions spanning the H2AX promoter, where PHAX has been shown to affect activity.